Changes In Israeli Law Facilitate Export Production

3 September 1995

Israel's Minister of Health, Ephraim Sneh, met recently with heads of the the country's medical industry within the framework of cooperation between the Ministry and the Israel Export Institute.

Dr Sneh declared to those present his policy, which encourages the Israeli medical industry locally and abroad, and as a first step towards achieving this goal he has initiated a change in the law which has already been implemented and which enables the industry to manufacture medical equipment for export only, thus opening new markets and opportunities to the local medical industry.

The Minister described the possibilities of cooperation with other countries which expanded during the last year due to the Ministry's initiative with nations such as Slovakia, Ukraine, Hungary, Lithuania, Kazakhstan, Egypt (interested in cooperation in the area of pharmaceuticals), Morocco (interested in acquiring diagnostics and imaging systems), Azerbaijan (interested in cooperation on the production of drugs and artificial limbs), Eritrea, Turkmenistan and others.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight